US Broker Ratings

Becton, Dickinson and Company (BDX) Stock Analysis: Insights into a Healthcare Giant’s 1.05% Potential Upside

Becton, Dickinson and Company (NYSE: BDX), a stalwart in the healthcare sector, commands a significant presence in the medical instruments and supplies industry. With a market capitalization of $57.58 billion,..

Ionis Pharmaceuticals (IONS) Stock Analysis: A Strategic Biotech with 6.17% Upside Potential

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a prominent player in the biotechnology sector, is capturing investor attention with its strategic focus on RNA-targeted medicines. With a market capitalization of $13.09 billion,..

Legend Biotech Corporation (LEGN) Stock Analysis: A Potential 223.95% Upside with Promising CAR-T Therapy Innovations

Legend Biotech Corporation (NASDAQ: LEGN) presents an intriguing opportunity for investors within the healthcare sector, particularly those with an interest in biopharmaceutical innovations. With a market capitalization of $4.12 billion,..

Bruker Corporation (BRKR) Investor Outlook: Analyzing a 10.16% Potential Upside

Bruker Corporation (NASDAQ: BRKR) is a prominent player in the healthcare sector, specifically within the medical devices industry. With its headquarters in Billerica, Massachusetts, Bruker has carved out a significant..

Summit Therapeutics Inc. (SMMT) Investor Outlook: A Biotech Play with 84.83% Potential Upside

Summit Therapeutics Inc. (NASDAQ: SMMT), with a market cap of $13.08 billion, presents a compelling opportunity for investors seeking exposure in the healthcare sector, specifically within the dynamic field of..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating a 3.37% Potential Upside in the Healthcare Sector

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the healthcare sector, has long been a name synonymous with innovation and quality in the pharmaceutical industry. Headquartered in Hyderabad,..

Danaher Corporation (DHR) Stock Analysis: Exploring a 13.15% Potential Upside and Robust Buy Ratings

Danaher Corporation (NYSE: DHR), a titan in the healthcare sector, operates at the forefront of diagnostics and research. With a market capitalization of $162.06 billion, Danaher offers a compelling narrative..

Globus Medical, Inc. (GMED) Stock Analysis: Strong Revenue Growth and Promising Upside Potential

Globus Medical, Inc. (NYSE: GMED), a leader in the medical devices sector, is capturing the attention of investors with its robust revenue growth and promising stock potential. With a market..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Exploring a 22% Potential Upside for Investors

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology sector, is capturing investor attention with its innovative approach to drug delivery and a promising potential upside. With a..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Unpacking a 135% Potential Upside

Telix Pharmaceuticals Limited (ASX: TLX), an innovative player in the biopharmaceutical sector, has captured investor attention with its robust pipeline of radiopharmaceutical products and a significant potential upside of 135.90%...

Masimo Corporation (MASI) Stock Analysis: Unlocking a Potential 32.82% Upside in the Healthcare Sector

Masimo Corporation (MASI), a prominent player in the medical devices industry, is catching the eye of investors with its promising potential upside of 32.82%. This Irvine, California-based company, known for..

Glaukos Corporation (GKOS): Investor Outlook and Key Metrics Highlighting a Promising 11.98% Upside

Glaukos Corporation (NYSE: GKOS) stands at the forefront of innovative solutions in the ophthalmic medical device sector, making it a fascinating prospect for investors within the healthcare industry. With a..

Humana Inc. (HUM) Investor Outlook: Exploring a 7.45% Potential Upside in Healthcare Plans

Humana Inc. (NYSE: HUM), a prominent player in the healthcare plans sector, is drawing considerable interest from investors with its solid performance and strategic positioning in a competitive industry. Headquartered..

Madrigal Pharmaceuticals, Inc. (MDGL): Investor Outlook on a Booming Biotech with 362% Revenue Growth

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has captured the attention of investors in the healthcare sector with its remarkable revenue growth and its strategic focus on developing novel therapeutics for metabolic..

Roivant Sciences (ROIV) Stock Analysis: A Promising Biotech with a 16% Upside Potential

Roivant Sciences Ltd. (NASDAQ: ROIV), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with a market capitalization of $15.37 billion. Based in London, United Kingdom, Roivant focuses..

argenx SE (ARGX) Stock Analysis: A Biotech Powerhouse with a 15% Upside Potential

argenx SE (ARGX), a prominent player in the biotechnology sector, commands significant attention with its cutting-edge therapies for autoimmune diseases. Based in Amsterdam, Netherlands, this commercial-stage biopharmaceutical company is making..

Stevanato Group S.p.A. (STVN) Investor Outlook: 37.56% Potential Upside Captures Attention

Italy-based Stevanato Group S.p.A. (NYSE: STVN) is making waves in the healthcare sector, particularly in the medical instruments and supplies industry. With a market capitalization of $5.68 billion, Stevanato is..

BioNTech SE (BNTX) Stock Analysis: Navigating a 46.33% Potential Upside in the Biotechnology Sector

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector, has captured the attention of investors with a significant potential upside of 46.33%, according to the latest analyst ratings...

Solventum Corporation (SOLV) Stock Analysis: Evaluating the 1.67% Potential Upside in Healthcare

Solventum Corporation (SOLV), a prominent player in the healthcare sector, has drawn significant attention from investors due to its comprehensive portfolio of medical instruments and supplies. Operating from its Maplewood,..

Hologic, Inc. (HOLX) Investor Outlook: Stability in Women’s Health Sector with Modest Upside

Hologic, Inc. (NASDAQ: HOLX), a formidable player in the healthcare sector, commands attention with its robust portfolio of diagnostics, medical imaging systems, and surgical products tailored for women’s health. With..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds